Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

U.K Tech Transfer Firm IP Group Raises $90 million To Support Early-Stage Portfolio Companies

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

IP Group raises funds to support academic spin-outs as VC funds and IPOs remain scarce

You may also be interested in...



Early-Stage Funding Gap Targeted By Two New U.K. Funds, Deepbridge Innovation Fund And Target Development Fund

Deepbridge Capital aims to raise £250 million to support early-stage research, recruits ex-GSK CEO Sykes to chair investment committee.

Early-Stage Funding Gap Targeted By Two New U.K. Funds, Deepbridge Innovation Fund And Target Development Fund

Deepbridge Capital aims to raise £250 million to support early-stage research, recruits ex-GSK CEO Sykes to chair investment committee.

Imperial Innovations Raises £140 Million To Invest In University Spin-Outs

The AIM-listed tech transfer group will increase its early-stage investments in spin-outs from Imperial College and three other top UK universities

Table

View full table

Topics

Tags:
BioPharmaceutical
Latest Headlines

UK Govt Under Fire From Pharma Industry Over Statutory Pricing Scheme Changes

US FDA’s October Outlook: Xphozah After Dispute, Santhera’s New Steroid For DMD, & Plenty Of Pfizer

Can Medicare Cover Obesity Drugs Without Congressional Action? Industry Builds Its Case

Pink Sheet Podcast: Adcomm Rejects NurOwn For ALS, FDA In Shutdown Mode, Limited Price Negotiation Savings

See All
UsernamePublicRestriction

Register

PS072469

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By